Fadi Francis joined Spartan Innovations as an Entrepreneur in Residence in September 2018. He is working with Spartan Innovations and the Early Learning Institute to explore the viability of expanding the Early Learning Institute’s work in early stage autism intervention therapy.
Dr. Vijay Baragi has a background in both large pharma and therapeutics startups and will be working with our companies IASO Therapeutics (Huang) and Tarn Biosciences (Abramovitch)
Mr. Forgey is an Entrepreneur-in-Residence (EIR) at Spartan Innovations, where he works closely with faculty and staff to facilitate the commercialization of new technologies discovered or developed at Michigan State University. Mr. Forgey is an entrepreneurial scientist and businessman with expertise in the founding, management and financing of early stage start-up companies. He has a specific expertise in the areas of drug discovery, drug development, and life science startup companies.
As the Communications Manager for the Michigan State University Foundation and its subsidiaries, Richard is responsible for clear communications, brand perception development, team leadership, and public relations. A committed storyteller, he strives to connect and engage audiences with vibrant content.
As the New Venture Associate, Gabriela works with Spartan Innovations and the MSU Foundation. With Spartan Innovations, she is responsible for providing administrative support to the Venture Creation Team. She also assists with the Fellows program and other various Venture Creation Team needs. Her role with the MSU Foundation is to manage the Technology Innovation Center, working with high-tech startup companies to expedite company growth and provide daily oversight and management to the business incubator space.
Frank Urban specializes in commercializing early stage therapeutics and diagnostics within the life sciences. Prior to Spartan Innovations, Frank was a Licensing Associate in the Office of Technology Commercialization at Wayne State University. Prior to that, he had varied business development, sales and scientific roles for a number of life science companies, to include Everist Genomics, Charles River Laboratories, MIR Preclinical Services, Molecular Imaging Products, Pfizer and Parke Davis. He has also worked as a consultant for numerous start-up companies and managed various laborator